Gawande looks to remove waste as he gears up to head healthcare initiative

After his  appointment as CEO of the new Amazon-Berkshire Hathaway-JPMorgan Chase healthcare venture, Atul Gawande, MD, stated the undertaking will look to target wasteful spending, while providing better outcomes and satisfaction and removing “some of the middlemen" from the system.

“My job for them is to figure out ways that we’re going to drive better outcomes, better satisfaction with care and better cost efficiency with new models that can be incubated for all,” Gawande said.

The venture is slated to target three types of waste in the healthcare system including administrative costs, high prices and “improper” healthcare usage, according to reporting from Bloomberg.com.

To read more, click the link below:

""

As a senior news writer for TriMed, Subrata covers cardiology, clinical innovation and healthcare business. She has a master’s degree in communication management and 12 years of experience in journalism and public relations.

Around the web

If the Trump administration continues taking a laissez-faire stance toward AI—including AI used in healthcare—why not let the states go it alone on regulating the technology? 

Boston Scientific has announced another significant M&A deal, scooping up an Israeli medtech company focused on RDN technology. 

Harvard’s David A. Rosman, MD, MBA, explains how moving imaging outside of hospitals could save billions of dollars for U.S. healthcare.